Cargando…

Evaluation of the clinical performance of 2 point‐of‐care cryptococcal antigen tests in dogs and cats

BACKGROUND: Point‐of‐care (POC) Cryptococcus antigen assays may provide veterinarians with a more rapid, patient‐side diagnosis when compared with traditional laboratory‐based latex agglutination tests. OBJECTIVE: To determine the sensitivity and specificity of 2 POC lateral flow cryptococcal serum...

Descripción completa

Detalles Bibliográficos
Autores principales: Reagan, Krystle L., McHardy, Ian, Thompson, George R., Sykes, Jane E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766525/
https://www.ncbi.nlm.nih.gov/pubmed/31468619
http://dx.doi.org/10.1111/jvim.15599
_version_ 1783454733167493120
author Reagan, Krystle L.
McHardy, Ian
Thompson, George R.
Sykes, Jane E.
author_facet Reagan, Krystle L.
McHardy, Ian
Thompson, George R.
Sykes, Jane E.
author_sort Reagan, Krystle L.
collection PubMed
description BACKGROUND: Point‐of‐care (POC) Cryptococcus antigen assays may provide veterinarians with a more rapid, patient‐side diagnosis when compared with traditional laboratory‐based latex agglutination tests. OBJECTIVE: To determine the sensitivity and specificity of 2 POC lateral flow cryptococcal serum antigen tests, CrAg LFA (Immy, Norman, OK) and the CryptoPS (Biosynex, Strasbourg, France) for diagnosis of cryptococcosis in dogs and cats, using the cryptococcal antigen latex agglutination system (CALAS) as the reference standard. ANIMALS: 102 serum samples from 51 dogs and 40 cats. METHODS: Specimens were classified as CALAS‐positive (n = 25) or CALAS‐negative (n = 77). The sensitivity and specificity of each POC assay was calculated by comparing the results to the serologic reference standard results. RESULTS: The CrAg LFA assay correctly classified 23/25 CALAS‐positive specimens and 69/74 CALAS‐negative specimens resulting in a sensitivity of 92.0% (confidence interval [CI], 75.0%‐98.6%) and specificity of 93.2% (CI, 85.1%‐97.1%). The CryptoPS assay correctly classified 8/10 tested CALAS‐positive specimens and 56/59 tested CALAS‐negative specimens resulting in a sensitivity of 80.0% (CI, 49.0%‐96.5%) and specificity of 94.9% (CI, 86.1%‐98.6%). CONCLUSION AND CLINICAL IMPORTANCE: The POC assays appear to be a sensitive and specific alternative to the traditional CALAS assay with more rapid turnaround times, which may result in earlier diagnosis and treatment.
format Online
Article
Text
id pubmed-6766525
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-67665252019-09-30 Evaluation of the clinical performance of 2 point‐of‐care cryptococcal antigen tests in dogs and cats Reagan, Krystle L. McHardy, Ian Thompson, George R. Sykes, Jane E. J Vet Intern Med SMALL ANIMAL BACKGROUND: Point‐of‐care (POC) Cryptococcus antigen assays may provide veterinarians with a more rapid, patient‐side diagnosis when compared with traditional laboratory‐based latex agglutination tests. OBJECTIVE: To determine the sensitivity and specificity of 2 POC lateral flow cryptococcal serum antigen tests, CrAg LFA (Immy, Norman, OK) and the CryptoPS (Biosynex, Strasbourg, France) for diagnosis of cryptococcosis in dogs and cats, using the cryptococcal antigen latex agglutination system (CALAS) as the reference standard. ANIMALS: 102 serum samples from 51 dogs and 40 cats. METHODS: Specimens were classified as CALAS‐positive (n = 25) or CALAS‐negative (n = 77). The sensitivity and specificity of each POC assay was calculated by comparing the results to the serologic reference standard results. RESULTS: The CrAg LFA assay correctly classified 23/25 CALAS‐positive specimens and 69/74 CALAS‐negative specimens resulting in a sensitivity of 92.0% (confidence interval [CI], 75.0%‐98.6%) and specificity of 93.2% (CI, 85.1%‐97.1%). The CryptoPS assay correctly classified 8/10 tested CALAS‐positive specimens and 56/59 tested CALAS‐negative specimens resulting in a sensitivity of 80.0% (CI, 49.0%‐96.5%) and specificity of 94.9% (CI, 86.1%‐98.6%). CONCLUSION AND CLINICAL IMPORTANCE: The POC assays appear to be a sensitive and specific alternative to the traditional CALAS assay with more rapid turnaround times, which may result in earlier diagnosis and treatment. John Wiley & Sons, Inc. 2019-08-29 2019 /pmc/articles/PMC6766525/ /pubmed/31468619 http://dx.doi.org/10.1111/jvim.15599 Text en © 2019 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals, Inc. on behalf of the American College of Veterinary Internal Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle SMALL ANIMAL
Reagan, Krystle L.
McHardy, Ian
Thompson, George R.
Sykes, Jane E.
Evaluation of the clinical performance of 2 point‐of‐care cryptococcal antigen tests in dogs and cats
title Evaluation of the clinical performance of 2 point‐of‐care cryptococcal antigen tests in dogs and cats
title_full Evaluation of the clinical performance of 2 point‐of‐care cryptococcal antigen tests in dogs and cats
title_fullStr Evaluation of the clinical performance of 2 point‐of‐care cryptococcal antigen tests in dogs and cats
title_full_unstemmed Evaluation of the clinical performance of 2 point‐of‐care cryptococcal antigen tests in dogs and cats
title_short Evaluation of the clinical performance of 2 point‐of‐care cryptococcal antigen tests in dogs and cats
title_sort evaluation of the clinical performance of 2 point‐of‐care cryptococcal antigen tests in dogs and cats
topic SMALL ANIMAL
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766525/
https://www.ncbi.nlm.nih.gov/pubmed/31468619
http://dx.doi.org/10.1111/jvim.15599
work_keys_str_mv AT reagankrystlel evaluationoftheclinicalperformanceof2pointofcarecryptococcalantigentestsindogsandcats
AT mchardyian evaluationoftheclinicalperformanceof2pointofcarecryptococcalantigentestsindogsandcats
AT thompsongeorger evaluationoftheclinicalperformanceof2pointofcarecryptococcalantigentestsindogsandcats
AT sykesjanee evaluationoftheclinicalperformanceof2pointofcarecryptococcalantigentestsindogsandcats